Treating disease at the level of the cell.
Cellarity is approaching medicine discovery and design from a new direction. Cellarity's platform relies on the characteristics of an entire cell's behaviour in the presence of disease, in contrast to traditional approaches which focus on identifying specific protein targets active in the spread of disease. Cellarity leverages both machine learning and transcriptomics (the study of RNA transcription) to identify the molecular networks within a cell that are activated when faced with disease, and identifies medicines that could counteract these changes.
Brain & AI
Genetics & Platform Technologies